MKI67 and neoplasm: In current practice, the P (Ki67+) and M (pH3+) populations of tumor cells are evaluated independently from a limited number of high-power tumor fields [49] and the predictive power of either variable alone may result in inaccurate patient risk stratification or clinical decision making.